Royalty Pharma plc

Royalty Pharma plcverified

RPRX

Price:

$26.61

Market Cap:

$12.03B

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematol...[Read more]

Industry

Biotechnology

IPO Date

2020-06-16

Stock Exchange

NASDAQ

Ticker

RPRX

The PE Ratio as of June 2024 (TTM) for Royalty Pharma plc (RPRX) is 14.95

According to Royalty Pharma plc’s latest financial reports and current stock price. The company's current PE Ratio is 14.95. This represents a change of -92.19% compared to the average of 191.40 of the last 4 quarters.

Royalty Pharma plc (RPRX) Historical PE Ratio (quarterly & annually)

How has RPRX PE Ratio performed in the past?

The mean historical PE Ratio of Royalty Pharma plc over the last ten years is 74.15. The current 14.95 PE Ratio has changed 1.92% with respect to the historical average. Over the past ten years (40 quarters), RPRX's PE Ratio was at its highest in in the March 2024 quarter at 701.85. The PE Ratio was at its lowest in in the March 2022 quarter at -148.32.

Quarterly (TTM)
Annual

Average

74.15

Median

13.03

Minimum

6.93

Maximum

404.10

Royalty Pharma plc (RPRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Royalty Pharma plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.07%

Maximum Annual PE Ratio = 404.10

Minimum Annual Increase = -97.26%

Minimum Annual PE Ratio = 6.93

Quarterly (TTM)
Annual
YearPE RatioChange
202311.08-97.26%
2022404.101.07%
202134.53-9.01%
202037.95447.33%
20196.93-39.39%
201811.44-12.17%

Royalty Pharma plc (RPRX) Average PE Ratio

How has RPRX PE Ratio performed in the past?

The current PE Ratio of Royalty Pharma plc (RPRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

149.90

5-year avg

98.92

10-year avg

74.15

Royalty Pharma plc (RPRX) PE Ratio vs. Peers

How is RPRX’s PE Ratio compared to its peers?

Royalty Pharma plc’s PE Ratio is greater than Prime Medicine, Inc. (-3.24), greater than Reneo Pharmaceuticals, Inc. (-0.78), greater than Ginkgo Bioworks Holdings, Inc. (-1.01), greater than Ocean Biomedical, Inc. (-0.27), greater than Adaptive Biotechnologies Corporation (-2.13), greater than VectivBio Holding AG (-7.94), greater than Kinnate Biopharma Inc. (-1.13), greater than Ikena Oncology, Inc. (-1.20), greater than Ascendis Pharma A/S (-13.18), greater than Apellis Pharmaceuticals, Inc. (-11.88), greater than BeiGene, Ltd. (-27.54), greater than Akero Therapeutics, Inc. (-7.58), greater than Blueprint Medicines Corporation (-22.19), greater than Iovance Biotherapeutics, Inc. (-4.78), greater than CureVac N.V. (-2.69), greater than Madrigal Pharmaceuticals, Inc. (-12.46), greater than Mirati Therapeutics, Inc. (-5.32), greater than IVERIC bio, Inc. (-33.43), greater than Amylyx Pharmaceuticals, Inc. (-1.57), greater than Karuna Therapeutics, Inc. (-29.52), greater than Day One Biopharmaceuticals, Inc. (-4.99),

Build a custom stock screener for Royalty Pharma plc (RPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Royalty Pharma plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Royalty Pharma plc (RPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Royalty Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Royalty Pharma plc's PE Ratio?

How is the PE Ratio calculated for Royalty Pharma plc (RPRX)?

What is the highest PE Ratio for Royalty Pharma plc (RPRX)?

What is the 3-year average PE Ratio for Royalty Pharma plc (RPRX)?

What is the 5-year average PE Ratio for Royalty Pharma plc (RPRX)?

How does the current PE Ratio for Royalty Pharma plc (RPRX) compare to its historical average?